INHA and tuberculosis: InhA associated enoyl ACP reductase, an enzyme responsible for fatty acid synthesis has been one of the best verified targets for the development of anti-TB drugs or InhA inhibitors that are found to be active only against sensitive TB but not against Multi-Drug Resistant (MDR) TB due to Kat G mutant selection [9].